Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years
Inspira Technologies (NASDAQ: IINN), a company focused on life-support and diagnostic technologies, has filed a routine shelf registration statement on Form F-3 with the SEC on August 6, 2025. This filing is part of the company's standard three-year shelf renewal process and will replace the previous registration statement expiring on August 18, 2025.
Inspira Technologies (NASDAQ: IINN), un'azienda specializzata in tecnologie di supporto vitale e diagnostica, ha presentato il 6 agosto 2025 una dichiarazione di registrazione ordinaria su Form F-3 alla SEC. Questa presentazione fa parte del consueto processo di rinnovo triennale della shelf registration della societ脿 e sostituir脿 la precedente dichiarazione di registrazione in scadenza il 18 agosto 2025.
Inspira Technologies (NASDAQ: IINN), una empresa enfocada en tecnolog铆as de soporte vital y diagn贸stico, present贸 el 6 de agosto de 2025 una declaraci贸n rutinaria de registro en shelf mediante el Formulario F-3 ante la SEC. Esta presentaci贸n forma parte del proceso est谩ndar de renovaci贸n trienal de la shelf registration de la compa帽铆a y reemplazar谩 la declaraci贸n previa que vence el 18 de agosto de 2025.
Inspira Technologies (NASDAQ: IINN)電� 靸濍獏 鞙犾 氚� 歆勲嫧 旮办垹鞐� 欷戩爯鞚� 霊� 須岇偓搿�, 2025雲� 8鞗� 6鞚� SEC鞐� Form F-3鞚� 韱淀暅 鞝曣赴 靹犽皹 霌彪 靹滊毳� 鞝滌稖頄堨姷雼堧嫟. 鞚� 鞝滌稖鞚� 須岇偓鞚� 響滌 3雲� 靹犽皹 臧膘嫚 鞝堨皑鞚� 鞚茧秬鞚措┌, 2025雲� 8鞗� 18鞚检棎 毵岆霅橂姅 鞚挫爠 霌彪 靹滊毳� 雽�觳错暊 鞓堨爼鞛呺媹雼�.
Inspira Technologies (NASDAQ : IINN), une entreprise sp茅cialis茅e dans les technologies de soutien vital et de diagnostic, a d茅pos茅 le 6 ao没t 2025 une d茅claration d'enregistrement standard sur formulaire F-3 aupr猫s de la SEC. Ce d茅p么t fait partie du processus habituel de renouvellement triennal de la shelf registration de la soci茅t茅 et remplacera la d茅claration d'enregistrement pr茅c茅dente expirant le 18 ao没t 2025.
Inspira Technologies (NASDAQ: IINN), ein Unternehmen, das sich auf lebenserhaltende und diagnostische Technologien spezialisiert hat, hat am 6. August 2025 eine routinem盲脽ige Shelf-Registrierungserkl盲rung auf Formular F-3 bei der SEC eingereicht. Diese Einreichung ist Teil des standardm盲脽igen dreij盲hrigen Shelf-Verl盲ngerungsprozesses des Unternehmens und ersetzt die vorherige Registrierungserkl盲rung, die am 18. August 2025 abl盲uft.
- None.
- None.
RA'ANANA, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inspira鈩� Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (鈥�Inspira,鈥� 鈥泪苍蝉辫颈谤补 Technologies,鈥� or the 鈥�Company鈥�), a pioneer in innovative life-support and diagnostic technologies, today announced that it has filed a shelf registration statement on Form F-3 (File No. 333-289324) with the U.S. Securities and Exchange Commission on August 6, 2025, as part of a routine shelf renewal process conducted every three years. This updated filing replaces the Company鈥檚 previous shelf registration statement, which is set to expire on August 18, 2025.
About Inspira Technologies
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The Company鈥檚 U.S. Food and Drug Administration -cleared INSPIRA鈩� ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures outside the U.S and serves as a foundation for the development of the INSPIRA ART500, a next-generation system designed to deliver oxygenation while patients remain awake and spontaneously breathing. Inspira Technologies is also advancing HYLA鈩�, a proprietary blood sensor platform offering continuous, non-invasive monitoring. With multiple cleared products, a growing IP portfolio, and strategic streamlining of its operations, Inspira Technologies is increasingly positioned as an attractive platform within the life-support and MedTech landscape. The Company鈥檚 recent internal shifts may reflect broader alignment with long-term industry trends, including consolidation, cross-sector collaboration, and potential strategic partnerships. For more information, visit: https://inspira-technologies.com
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at .
Company Contact
Inspira Technologies 鈥� Media Relations
Email: [email protected]
Phone: +972-9-9664485
FAQ
What is the purpose of Inspira Technologies' (IINN) Form F-3 filing in August 2025?
When did Inspira Technologies (IINN) file its latest Form F-3 registration statement?
How often does Inspira Technologies (IINN) need to renew its shelf registration statement?
What type of company is Inspira Technologies (IINN)?
